MRVI logo

Maravai LifeSciences Holdings (MRVI) CAPEX

Annual CAPEX

$65.55 M
+$48.46 M+283.58%

31 December 2023

MRVI CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

$9.59 M
+$38.00 K+0.40%

30 September 2024

MRVI Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

$41.61 M
-$6.24 M-13.03%

30 September 2024

MRVI TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRVI CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+283.6%-39.4%-24.3%
3 y3 years+158.0%+621.7%+130.6%
5 y5 years+1715.4%--

MRVI CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+341.4%-61.7%+621.7%-36.5%+265.2%
5 y5 yearsat high+1715.4%-61.7%+621.7%-36.5%+1120.5%
alltimeall timeat high+1715.4%-61.7%+621.7%-36.5%+1120.5%

Maravai LifeSciences Holdings CAPEX History

DateAnnualQuarterlyTTM
Sept 2024
-
$9.59 M(+0.4%)
$41.61 M(-13.0%)
June 2024
-
$9.55 M(+68.6%)
$47.84 M(-24.5%)
Mar 2024
-
$5.67 M(-66.3%)
$63.35 M(-3.4%)
Dec 2023
$65.55 M(+283.6%)
$16.80 M(+6.1%)
$65.55 M(+19.3%)
Sept 2023
-
$15.83 M(-36.8%)
$54.97 M(+20.5%)
June 2023
-
$25.06 M(+218.5%)
$45.61 M(+105.3%)
Mar 2023
-
$7.87 M(+26.6%)
$22.21 M(+30.0%)
Dec 2022
$17.09 M
$6.21 M(-3.9%)
$17.09 M(+3.4%)
Sept 2022
-
$6.47 M(+289.3%)
$16.53 M(+45.1%)
June 2022
-
$1.66 M(-39.6%)
$11.39 M(-20.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
$2.75 M(-51.4%)
$14.27 M(-3.9%)
Dec 2021
$14.85 M(-41.6%)
$5.66 M(+325.6%)
$14.85 M(-17.7%)
Sept 2021
-
$1.33 M(-70.7%)
$18.04 M(-32.7%)
June 2021
-
$4.53 M(+36.0%)
$26.80 M(+5.8%)
Mar 2021
-
$3.33 M(-62.3%)
$25.33 M(-0.3%)
Dec 2020
$25.41 M(+48.2%)
$8.85 M(-12.3%)
$25.41 M(+53.4%)
Sept 2020
-
$10.09 M(+229.9%)
$16.56 M(+156.0%)
June 2020
-
$3.06 M(-10.3%)
$6.47 M(+89.7%)
Mar 2020
-
$3.41 M
$3.41 M
Dec 2019
$17.15 M(+374.9%)
-
-
Dec 2018
$3.61 M
-
-

FAQ

  • What is Maravai LifeSciences Holdings annual capital expenditures?
  • What is the all time high annual CAPEX for Maravai LifeSciences Holdings?
  • What is Maravai LifeSciences Holdings annual CAPEX year-on-year change?
  • What is Maravai LifeSciences Holdings quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Maravai LifeSciences Holdings?
  • What is Maravai LifeSciences Holdings quarterly CAPEX year-on-year change?
  • What is Maravai LifeSciences Holdings TTM capital expenditures?
  • What is the all time high TTM CAPEX for Maravai LifeSciences Holdings?
  • What is Maravai LifeSciences Holdings TTM CAPEX year-on-year change?

What is Maravai LifeSciences Holdings annual capital expenditures?

The current annual CAPEX of MRVI is $65.55 M

What is the all time high annual CAPEX for Maravai LifeSciences Holdings?

Maravai LifeSciences Holdings all-time high annual capital expenditures is $65.55 M

What is Maravai LifeSciences Holdings annual CAPEX year-on-year change?

Over the past year, MRVI annual capital expenditures has changed by +$48.46 M (+283.58%)

What is Maravai LifeSciences Holdings quarterly capital expenditures?

The current quarterly CAPEX of MRVI is $9.59 M

What is the all time high quarterly CAPEX for Maravai LifeSciences Holdings?

Maravai LifeSciences Holdings all-time high quarterly capital expenditures is $25.06 M

What is Maravai LifeSciences Holdings quarterly CAPEX year-on-year change?

Over the past year, MRVI quarterly capital expenditures has changed by -$6.24 M (-39.40%)

What is Maravai LifeSciences Holdings TTM capital expenditures?

The current TTM CAPEX of MRVI is $41.61 M

What is the all time high TTM CAPEX for Maravai LifeSciences Holdings?

Maravai LifeSciences Holdings all-time high TTM capital expenditures is $65.55 M

What is Maravai LifeSciences Holdings TTM CAPEX year-on-year change?

Over the past year, MRVI TTM capital expenditures has changed by -$13.36 M (-24.31%)